Lanthionine antibiotic compositions and methods
US7655236B2 · kind B2 · utility
0Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2004 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Jan 4, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to the present invention, an isolated and purified DNA sequence which encodes a lantibiotic, mutacin I, is disclosed. The nucleic acid sequence is set forth in SEQ ID No: 1 and the amino acid sequence is set forth in SEQ ID No: 2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.